Virtual multidisciplinary GI care is moving from pilot data to scaled performance metrics.
Oshi Health released its 2025 Impact Report, presenting expanded real-world outcomes across its national patient population and matched claims analyses. The company reports sustained improvements in symptom control, preventive care compliance, and healthcare cost reduction—positioning its virtual-first GI model as a population-level intervention rather than a niche telehealth solution.
Clinical Outcomes at Scale
Across nationwide analyses through year-end 2025:
- 97% of patients achieved symptom control
- Moderate-to-severe symptoms declined by 90%
- Most patients achieved control within three months
- Nearly half received a new GI diagnosis, clarifying care pathways
Subpopulation findings presented at ACG 2025 showed similar consistency:
- IBD: 90% symptom control
- Medicare-aged patients: 95% symptom control
- Chronic liver disease: 86% symptom control
Patient satisfaction reached 97–100% across cohorts